A new challenge from XPrize seeks evidence-based models using artificial intelligence to help governments reopen their economies during the pandemic. . . . → Read More: $500K Challenge Seeks A.I. Covid-19 Reopening Models
|
|||||
A new challenge from XPrize seeks evidence-based models using artificial intelligence to help governments reopen their economies during the pandemic. . . . → Read More: $500K Challenge Seeks A.I. Covid-19 Reopening Models If you’ve been living or studying in the UK for a minimum of five years, you are eligible to apply for indefinite leave to remain. . . . → Read More: What to Know About Indefinite Leave To Remain Visas Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective Researchers devised a technique that in lab mice carries immune system enzymes on red blood cells to stop the spread of cancer in the lungs. . . . → Read More: Blood Cells Transport Enzymes to Slow Cancer Spread Interim clinical trial results show the Moderna Covid-19 vaccine prevents infection in 94 percent of cases and can stored for 30 days in normal refrigeration. . . . → Read More: Covid-19 Vaccine Shown Effective, Temperature-Stable With Covid-19 cases in the U.S. accelerating in the past few weeks, a recent poll shows the public clearly favors a lockdown to stop the rise. . . . → Read More: Infographic: U.S. Public Supports Lockdown Four companies from the computer technology and genomics industries are starting a coalition to advance DNA as a data storage medium. . . . → Read More: Tech, Genomics Companies Form DNA Storage Alliance A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles. . . . → Read More: Start-Up Gains Drug Nanoparticle Manufacturing Tech A test to detect Covid-19 viruses in saliva rather than nasal swabs received emergency authorization from Food and Drug Administration. . . . → Read More: Covid-19 Saliva Test Earns FDA Emergency Clearance A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round. . . . → Read More: Gene-Editing Enzyme Start-Up Gains $65M |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |